(Q40305945)

19 September 2017

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. (English)

1 reference

19 September 2017

0 references

Ohnishi A

1

1 reference

19 September 2017

Orita Y

2

1 reference

19 September 2017

Okahara R

3

1 reference

19 September 2017

Fujihara H

4

1 reference

19 September 2017

Inoue T

5

1 reference

19 September 2017

Yamamura Y

6

1 reference

19 September 2017

Yabuuchi Y

7

1 reference

19 September 2017

Tanaka T

8

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

Journal of Clinical Investigation

19 September 2017

1 reference

19 September 2017

92

1 reference

19 September 2017

6

1 reference

19 September 2017

2653-2659

1 reference

Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma

19 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Discovery, development, and some uses of vasopressin and oxytocin antagonists

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Sodium transport by rat cortical collecting tubule. Effects of vasopressin and desoxycorticosterone

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Vasopressin agonists and antagonists

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

The osmoregulation of vasopressin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Further studies on the role of angiotensin in the osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activity

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288462

Pharmacokinetics, safety, and pharmacologic effects of OPC-21268, a nonpeptide orally active vasopressin V1 receptor antagonist, in humans

20 August 2018

1 reference

12 December 2020

Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure

1 reference

12 December 2020

Role of vasopressin in abnormal water excretion in cirrhotic patients

1 reference

12 December 2020

Increased plasma arginine vasopressin levels in patients with congestive heart failure

1 reference

12 December 2020

Chronic blockade of vasopressin receptors in rats

1 reference

12 December 2020

Vasopressin antagonism in the squirrel monkey (Saimiri sciureus)

1 reference

12 December 2020

No requirement of cyclic conformation of antagonists in binding to vasopressin receptors

1 reference

12 December 2020

SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta)

1 reference

12 December 2020

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI116881

1 reference

19 September 2017

1 reference

19 September 2017

PubMed publication ID

8254021

1 reference